|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-06A1
|
$2,300,000
|
$2,300,000
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$30,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$3,750
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
|
1R01CA164225-01A1
|
$334,420
|
$334,420
|
Wang, Li
|
DARTMOUTH COLLEGE
|
|
|
Virus-Like Particle Based Antigen Display as Multi-component Anticancer Vaccines
|
5R01CA149451-02
|
$476,018
|
$238,009
|
HUANG, XUEFEI
|
MICHIGAN STATE UNIVERSITY
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
$6,080
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Outpatient Clinic File
|
ZIA CP010126-00580
|
$74,164
|
$3,708
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
Vesicular stomatitis VSVrp30 selectively destroys human metastatic melanoma
|
1R01CA161048-01A1
|
$344,191
|
$344,191
|
VAN DEN POL, ANTHONY
|
YALE UNIVERSITY
|
|
|
VEGFs in tumor lymphatic metastasis
|
5R01CA142262-04
|
$452,526
|
$316,768
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-22S1
|
$139,963
|
$1,400
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-22
|
$399,112
|
$3,991
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-05
|
$1,070,400
|
$32,112
|
Gore, John
|
VANDERBILT UNIVERSITY MED CTR
|
|
|
Validation of Genomic Targets in Melanoma
|
5R01CA114337-08
|
$351,145
|
$351,145
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
5R01CA140375-03
|
$296,440
|
$148,220
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells
|
5R01CA140602-03
|
$395,213
|
$395,213
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$91,114
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$1,497
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$2,800
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UV/Vit D in radiologic technologists
|
ZIA CP010133-10416
|
$248,881
|
$49,776
|
Freedman, Daryl
|
DCEG (NCI)
|
|
|
Uses of GEM models for Translational Cancer Research
|
7U01CA141508-04
|
$760,324
|
$380,162
|
CHIN, LYNDA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Use of aAPC for Melanoma Adoptive Immunotherapy
|
5R01CA108835-07
|
$318,780
|
$318,780
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S1
|
$50,000
|
$1,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S2
|
$246,000
|
$4,920
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S3
|
$74,999
|
$1,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-37
|
$6,285,726
|
$125,715
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
$8,210
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
2P30CA046592-24
|
$5,694,947
|
$56,949
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S1
|
$49,948
|
$499
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S2
|
$74,872
|
$749
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-05
|
$1,565,163
|
$156,516
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-13
|
$1,150,000
|
$34,500
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Tumor Microenvironment in Cancer Progression
|
ZIABC011332
|
$343,873
|
$17,194
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
|
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
|
ZIABC010954
|
$482,717
|
$96,543
|
Hurwitz, Arthur
|
CCR (NCI)
|
|
|
Tumor -Targeting Chemotherapeutic Agents
|
5R01CA103314-21
|
$314,565
|
$78,641
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
|
Tulane Medical/Cancer Center Minority-Based Community Clinical Oncology Program
|
1U10CA167782-01
|
$700,000
|
$7,000
|
ROBINSON, WILLIAM
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Treatment of Melanoma with Optimzed Peptide Vaccines
|
5R01CA136828-04
|
$336,129
|
$336,129
|
Celis, Esteban
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Translational Research in Cancer
|
3P30CA056036-13S1
|
$74,459
|
$3,723
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translational Research in Cancer
|
5P30CA056036-13
|
$2,947,311
|
$147,366
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Transduction of T cells to improve migration to tumor
|
5R01CA116206-08
|
$335,525
|
$335,525
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Topic 267, Multifunctional Therapeutics Using Engineered Plant Virus Nanoparticle
|
N44CO120038-000
|
$1,199,956
|
$1,199,956
|
OBERHARDT, BRUCE
|
NANOVECTOR INCORPORATED
|
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-29
|
$700,123
|
$7,001
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
|
Tissue Array Research Program
|
ZICBC010923
|
$565,426
|
$84,814
|
Hewitt, Stephen
|
CCR (NCI)
|
|
|
Therapeutic use of immunomodulators and ionizining radiation
|
ZIABC011455
|
$121,134
|
$39,974
|
Haglund, Karl
|
CCR (NCI)
|
|
|
Therapeutic Potential of IL-15 Plasmid Delivery to Tumors Using Electroporation
|
5R01CA122518-05
|
$261,203
|
$261,203
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
|
Therapeutic approaches that target cancer cell metabolism
|
5K23CA120862-05
|
$137,295
|
$96,107
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
2U10CA045809-24
|
$1,389,595
|
$69,480
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
|
5P50CA093459-08
|
$2,272,914
|
$2,272,914
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
The Unfolded Protein Response in Melanoma Progression and Chemoresistance
|
5R01CA125017-06
|
$224,100
|
$224,100
|
SOENGAS, MARIA
|
SPANISH NATIONAL CANCER CENTER
|
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-13
|
$1,415,212
|
$254,738
|
Herschman, Harvey
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
|
The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis
|
ZIASC009179
|
$529,889
|
$264,945
|
Stetler-Stevenson, William
|
CCR (NCI)
|
|
Total relevant funding to Melanoma for this search: $121,196,691
|
